The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...

Venus Remedies receives marketing authorisation for Sugammadex in the Philippines, marking a major step in its expansion into complex generics and the ASEAN market. Sugammadex is a relaxant-binding ...

ANI Pharmaceuticals beat Q4 estimates with strong sales growth and raised its 2025 revenue and EPS outlook, driven by ...

​Here are a few facts about egg laying chickens: 1. Breeds for Egg Production – Popular laying breeds include White Leghorns ...

Nomura has a Buy rating on Cipla after the company's MD reassured that the competitiveness of the Indian generics biz won't ...

The acquisition will be funded through the Initial Public Offer proceeds raised by Senores Pharmaceuticals Limited.

Venus Remedies receives marketing authorization for Sugammadex from Philippines: Our Bureau, Mumbai Tuesday, March 4, 2025, 15:40 Hrs [IST] Venus Remedies Limited, a leading India ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

The basket acquired, comprises of 13 ANDAs, which are approved by the US Food anf Drugs Administration (US FDA) and 1 ANDA, ...